Work

Abstract B086: Anchored in Resistance: Overcoming Nidogen-2 (NID2) - mediated Immunoresistance in Ovarian Cancer with Ras and Bcl-xl Inhibition

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-b086

Authors: Fabian BT. Kraus, Mengyao Xu, Raj Kumar, Irva Veillard, Will B. Manning, Timothy S. Bond, Eugene Kim, Yusuke Matoba, Maryam Azimi, Bastian Czogalla, Sven Mahner, Fabian Trillsch, Bo R. Rueda, David R. Spriggs, Oladapo O. Yeku

Institutions: Harvard University, Massachusetts General Hospital, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Ludwig-Maximilians-Universität München

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444707

Cites:

Cited by:

Related to: